Tuesday, February 17, 2015
Congratulate Alberta Glycomics Centre for Their Leadership in the Collaborative Successful Funding of $27.3M for GlycoNet- A Canadian Glycomics Network
Monday, November 10, 2014
Developing treatments for patients with cardiovascular disease, diabetes mellitus, Alzheimer's disease, peripheral artery disease, and chronic kidney disease.
Tuesday, October 14, 2014
Quest PharmaTech Inc., a publicly traded, Alberta-based biotechnology company, is committed to the development and commercialization of oncology products.